Details for New Drug Application (NDA): 019978
✉ Email this page to a colleague
NDA 019978 describes BUPIVACAINE HYDROCHLORIDE KIT, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the BUPIVACAINE HYDROCHLORIDE KIT profile page.
The generic ingredient in BUPIVACAINE HYDROCHLORIDE KIT is bupivacaine hydrochloride. There are twelve drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride profile page.
The generic ingredient in BUPIVACAINE HYDROCHLORIDE KIT is bupivacaine hydrochloride. There are twelve drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride profile page.
Summary for 019978
| Tradename: | BUPIVACAINE HYDROCHLORIDE KIT |
| Applicant: | Hospira |
| Ingredient: | bupivacaine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.075% | ||||
| Approval Date: | Sep 3, 1992 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.114% | ||||
| Approval Date: | Sep 3, 1992 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.23% | ||||
| Approval Date: | Sep 3, 1992 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
